http://thefederalregister.com/b.p/agency/Food_and_Drug_Administration/2008-06-11/ Daily Publications of Meetings and Rules Changes for the Federal Government Mon, Dec 1 2008 11:00:00 GMT Mon, Dec 1 2008 11:00:00 GMT info@thefederalregister.com http://thefederalregister.com/d.p/2008-06-11-E8-13122 ]]> http://thefederalregister.com/d.p/2008-06-11-E8-13122 Wed, Jun 11 2008 11:00:00 GMT http://thefederalregister.com/d.p/2008-06-11-E8-13109 ]]> http://thefederalregister.com/d.p/2008-06-11-E8-13109 Wed, Jun 11 2008 11:00:00 GMT http://thefederalregister.com/d.p/2008-06-11-E8-13099 (aripiprazole), ANDROGEL (testosterone), and DIOVAN (valsartan). These summaries are being made available consistent with the Best Pharmaceuticals for Children Act, enacted in 2002, (the 2002 BPCA). For all pediatric supplements submitted under the 2002 BPCA, the 2002 BPCA required FDA to make available to the public, including by publication in the Federal Register, a summary of the medical and clinical pharmacology reviews of the pediatric studies conducted for the supplement. ]]> http://thefederalregister.com/d.p/2008-06-11-E8-13099 Wed, Jun 11 2008 11:00:00 GMT